Cite
HARVARD Citation
Hsu, R. et al. (n.d.). 1288. US Healthcare Provider Perspectives on the initiation of cabotegravir and rilpivirine long-acting (CAB+RPV LA) in an observational real-world study (BEYOND). Open forum infectious diseases. p. . [Online].